insights_auto
Why is EDIT down 3,61%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,40 US$
arrow_downward
-3,61%(-0,090) 1D
2,44 US$
arrow_upward
+1,53% (+0,037)bedtimeAfter hours
Closed: 23 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,44 US$
High
2,45 US$
Low
2,30 US$
Mkt. cap
368,59 მლნ.
Avg. vol.
2,92 მლნ.
Volume
1,31 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,44 US$
High
2,45 US$
Low
2,30 US$
Mkt. cap
368,59 მლნ.
Avg. vol.
2,92 მლნ.
Volume
1,31 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
TradingView
·
26 წუთის წინ
Nasdaq Futures Slip Amid Tech Selloff While S&P 500, Dow Edge Higher Ahead Of Crucial Earnings Week: IREN, CRWV, NBIS, MRNA, EWZ In Focus
Koreabizwire
·
58 წუთის წინ
Nasdaq Strengthens Asia-Pacific Leadership Team
Moomoo
·
1 საათის წინ
The highlight of earnings season has arrived: Over one-third of S&P 500 companies are set to report results this week!
Bloomberg.com
·
13 საათის წინ
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc